Concepedia

Jose Antonio Ortega

JA

Statistics

Publications

4

Citations

124

H-Index

4

Active since

2020

Affiliations

Italian Institute of Technology(Current)

University of Bologna

University of Basel

Paul Scherrer Institute

Jose Antonio Ortega is an author at Italian Institute of Technology specializing in drug discovery, drug design, and pharmacy.

ORCID

Publications per year

2020–2025

4

Publications

4

Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib

Greta Bagnolini, Domenico Milano, Marcella Manerba et al. · Journal of Medicinal Chemistry · 2020 · 53 citations · Full text

, , +16

Rational Design of a Novel Tubulin Inhibitor with a Unique Mechanism of Action

Tobias Mühlethaler, Lampros Milanos, Jose Antonio Ortega et al. · Angewandte Chemie International Edition · 2022 · 31 citations · Full text

, , +17

Novel fragment-derived colchicine-site binders as microtubule-destabilizing agents

Noelia Montel de la Roche, Tobias Mühlethaler, Rita Maria Concetta Di Martino et al. · European Journal of Medicinal Chemistry · 2022 · 29 citations · Full text

, , +14

Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity

Mirco Masi, Laura Poppi, Viola Previtali et al. · Cell Death Discovery · 2025 · 11 citations · Full text

, , +17

1–4 of 4